Loader

Please wait...

Canadian Pharmacists Association
Canadian Pharmacists Association
Share
Facebook Share
Twitter Share
LinkedIn Share
Google Plus Share
Email Share

CPhA Committees & Working Groups

In an effort to incorporate regional perspectives and draw on expertise from pharmacists and other members of the health care community from across the country, CPhA has formed a range of committees and working groups.  The following committees and working groups help to inform CPhA’s policies and positions and guide its activities.

Advocacy Committee

The Advocacy Committee is a Standing Committee of CPhA’s Board of Directors responsible for developing the organization’s advocacy agenda. The Committee works to develop CPhA’s national policies, policy frameworks and criteria for engaging others to enhance CPhA membership interests in the area of advocacy and government relations on behalf of the profession of pharmacy.

Membership:

  • Jim Armour (Chair)
  • Joseph Amiel, 1er vice-président, Association québécoise des pharmaciens propriétaires
  • Neil Cameron (CPhA Board Representative)
  • Mark Dickson (CPhA Board Representative)
  • Andrew Gall, CEO, Ontario Pharmacists Association
  • Christine Hrudka, CPhA Vice Chair (CPhA Board Representative)
  • Susan Mansour, College of Pharmacy, Dalhousie University (CPhA Board Representative)
  • Dawn Martin, Executive Director, Pharmacy Association of Saskatchewan
  • Perry Martin, Vice-President, Government Relations, Shoppers Drug Mart
  • Alistair Bursey, CPhA Chair*
  • Glen Doucet, CPhA Interim CEO*

*ex-officio

Third-Party Payer Working Group

The Third Party Payer Working Group assists CPhA in supporting its mission and Organizational Members on issues related to pharmacists’ relationships with public and private payers. The Working Group identifies issues with public and private payer policies, processes and procedures that impact pharmacists’ ability to deliver quality care to their patients, develops consensus and communications, and identifies strategies to address these issues and improve working relationships with third-party payers.

Membership:

  • Paul Blanchard (New Brunswick Pharmacists’ Association)
  • Allison Bodnar (Pharmacy Association of Nova Scotia)
  • Linda Gutenberg (British Columbia Pharmacy Association)
  • Ramy Fahmy-Demain (Association québécoise des pharmaciens propriétaires)
  • Allan Malek (Ontario Pharmacists Association)
  • Erin MacKenzie (Prince Edward Island Pharmacists Association)
  • Jennifer Collingwood (Pharmacists’ Association of Newfoundland and Labrador)
  • Brenna Shearer (Pharmacists Manitoba)
  • Matt Tachuk (Alberta Pharmacists’ Association)
  • Myla Wollbaum (Pharmacy Association of Saskatchewan)

Professional Practice Working Group

The Professional Practice Working Group is tasked with defining and developing a forward-thinking, uniformed national scope of practice for the pharmacy profession in Canada. The Group will also help identify practice and economic research required to support its vision for a harmonized national scope of practice.

Membership:

  • Hans B. Epp, Shoppers Drug Mart Pharmacist/Owner, MB
  • Stacey D’Angelo, Co-Founder & Pharmacist, Wellth Pharmacy Plus Clinic, ON
  • Derek Jorgenson, Professor of Pharmacy, University of Saskatchewan, Director of the Medication Assessment Centre, SK
  • Ray Joubert, Associate Registrar, Saskatchewan College of Pharmacy Professionals, SK
  • Natalie Kennie-Kaulbach, University Teaching Fellow, College of Pharmacy, Dalhousie University; Pharmacy Consultant, Dalhousie Family Medicine, NS
  • Simon Lessard, Pharmacist Owner & Practitioner and Lecturer, University of Montreal, QC
  • Matt Tachuk, Director of Pharmacy Practice, Alberta Pharmacists’ Association (RxA), AB
  • Lisa Woodill, PANS Director of Pharmacy Practice and Community Pharmacist, NS
  • Alistair Bursey, Ex Officio, CPhA Board Chair, Pharmacist Owner, NB
  • Iris Krawchenko (Chair), Senior Pharmacist Advisor, CPhA

CPhA-AFPC Pharmacy Workforce Planning Committee

The CPhA-AFPC Pharmacy Workforce Planning Committee was convened in July 2016 to conduct a comprehensive assessment of the current and future pharmacist workforce, focusing on both the supply and demand for pharmacists. Membership is pan-Canadian, and includes representation from across the pharmacy community (including professional associations, regulators, educators, and accreditors).

Membership:

  • Canadian Pharmacists Association (CPhA)
  • Canadian Association of Faculties of Pharmacy (AFPC)
  • Canadian Association of Pharmacy Students and Interns (CAPSI)
  • Canadian Council for the Accreditation of Pharmacy Programs (CCAPP)
  • Canadian Council on Continuing Education in Pharmacy (CCCEP)
  • Canadian Society of Hospital Pharmacists (CSHP)
  • Association des pharmaciens des établissements de santé du Québec (APES)
  • National Association of Pharmacy Regulatory Authorities (NAPRA)
  • Canadian Association of Pharmacy Technicians (CAPT)
  • Canadian Pharmacy Technicians Educators Association (CPTEA)
  • Pharmacy Examining Board of Canada (PEBC)
  • Neighbourhood Pharmacy Association of Canada (NPAC)
  • Provincial pharmacy regulatory organizations
  • Provincial pharmacy associations

Pharmacare Consensus Working Group

The Pharmacare Consensus Working Group is a collaboration between the Canadian Pharmacists Association, the Best Medicines Coalition, and the Health Care Charities Coalition of Canada. The Working Group was formed in 2016 to build consensus around the core components, principles and priorities of a pan-Canadian pharmaceutical care strategy that reflects the needs of patients and supports health providers in delivering the best possible care.

Membership:

  • Seema Nagpal (Health Charities Coalition of Canada/Canadian Diabetes Association)
  • Connie Cote (Health Charities Coalition of Canada)
  • Helena Sonea (Health Charities Coalition of Canada)
  • Lesley James (Health Charities Coalition of Canada/Heart and Stroke Foundation)
  • Paulette Eddy (Best Medicines Coalition)
  • John Adams (Best Medicines Coalition/Canadian PKU and Allied Disorders)
  • Gail Attara (Best Medicines Coalition/Gastrointestinal Society)
  • Deb Saltmarche (CPhA/Shoppers Drug Mart)
  • Carlo Berardi (CPhA)

National Pharmacy Continuing Professional Development (CPD) Working Group

The National CPD Working Group facilitates engagement, coordination and consultation between CPhA and its Organizational Members on CPD for pharmacists. The Working Group also monitors CPD availability, needs and gaps; and advises CPhA and its Organizational Members on appropriate development and delivery of CPD programs.

Membership:

  • Alberta Pharmacists’ Association
  • Association québécoise des pharmaciens propriétaires
  • British Columbia Pharmacy Association
  • Pharmacists Manitoba
  • New Brunswick Pharmacists’ Association
  • Ontario Pharmacists Association
  • Pharmacists’ Association of Newfoundland and Labrador
  • Pharmacy Association of Nova Scotia
  • Pharmacy Association of Saskatchewan
  • Prince Edward Island Pharmacists Association

CPPRG Executive Committee

The aim of the Canadian Pharmacy Practice Research Group (CPPRG) is to provide leadership in the generation, dissemination and application of practice-based research evidence to optimize the role of pharmacists in medication management and improved patient outcomes (Executive Committee members)

Inactive Committees

In addition to active committees and working groups, several now disbanded groups were formed to carry out consultations for specific policy initiatives.

Opioid Working Group

The Opioid Working Group was formed in October 2016 to inform CPhA’s commitments to the government-led Joint Statement of Action to Address the Opioid Crisis. The Working Group made recommendations in the areas of information technology to support responsible prescribing, collaborative approaches addressing prescription opioid misuse, and regulatory change to leverage the role of pharmacists. The group also played an advisory role in the preparation and planning for CPhA’s Opioid Summit in June 2017.

Membership:

  • Mark Barnes (Pharmacist Owner, Addiction Specialist)
  • Deb Saltmarche (Shoppers Drug Mart)
  • Mark Dickson (BC Pharmacy Association)
  • Alistair Bursey (CPhA)
  • Derek Desrosiers (BC Pharmacy Association)
  • Allan Malek (Ontario Pharmacists Association)
  • Mike Namaka (University of Manitoba)

Pharmacare Principles & Priorities Advisory Panel

The Pharmacare Principles & Priorities Advisory Panel was formed in Spring 2015 to advise on the creation of CPhA’s Pharmacare 2.0 Principles & Priorities. The Committee was disbanded following the document’s release in September 2015.

Membership:

  • Allan Malek (Ontario Pharmacists Association)
  • Dawn Martin (Pharmacy Association of Saskatchewan)
  • Genevieve Pelletier (Pfizer)
  • Jeff Connell (Canadian Generic Pharmaceutical Association)
  • Lesia Babiak (Johnson and Johnson)
  • Owen Adams (Canadian Medical Association)
  • Seema Nagpal (Canadian Diabetes Association)
  • Trent Lane (Pharmasave)
  • Deb Saltmarche (Shoppers Drug Mart)

Medical Marijuana Policy Working Group

The Medical Marijuana Working Group was formed in Summer 2015 to review CPhA’s policy on medical marijuana and advise on a KPMG report. The Group was disbanded following approval of CPhA’s new policy in March 2016.

Membership:

  • Christine Hughes (University of Alberta)
  • Deb Saltmarche (Shoppers Drug Mart)
  • Dennis Darby (Ontario Pharmacists Association)
  • Derek Desrosiers (BC Pharmacy Association)
  • Erin MacKenzie (PEI Pharmacists Association)
  • Loren Regier (Rx Files)
  • Mark Barnes (Pharmacist Owner, Addiction Specialist)
  • Mike Namaka (University of Manitoba)
  • Rose Dipchand (Pharmacy Association of Nova Scotia)
  • Bob Nakagawa (College of Pharmacists of BC)

Assisted Dying Working Group

The Assisted Dying Policy Working Group was an ad hoc working group formed in September 2015 to create CPhA policy on pharmacist involvement in medical assistance in dying. The Group oversaw a national survey of 1000+ individual pharmacists and advised on CPhA’s submissions to both Liberal and Conservative governments. The Group was disbanded in February 2016 following public release of CPhA’s policy position.

Membership:

  • Rose Dipchand (Pharmacy Association of Nova Scotia)
  • John Hawboldt (Memorial University)
  • Ray Joubert (Saskatchewan College of Pharmacists)
  • Iris Krawchenko (Pharmacist Consultant)
  • Barret Procyshyn (CPhA)
  • Jane Richardson (University of Saskatchewan)
  • Cheryl Sadowski (University of Alberta)
  • Jean Thiffault (Association québécoise des pharmaciens propriétaires)
  • Sally Tierney (Bruyere Continuing Care)
  • Margaret Wing (Alberta Pharmacists’ Association)

External Committees & Working Groups

In addition to CPhA-led committees, the Association is also a member of several external groups.

Pharmacy and Health Insurance Steering Coalition (PHISC)

PHISC is a forum to facilitate ongoing discussion between senior representatives of private sector insurers and pharmacy. PHISC identifies common areas of interest to leverage the role of pharmacists in benefit plan management to achieve positive health outcomes for plan members/patients and cost management goals for plan sponsors, identifies opportunities for collaboration to reduce costs of administration of third party plans for pharmacy providers and private payers administrators, and enhances customer service to plan members/patients, plan sponsors, and pharmacists.

AMS Canada Steering Committee

CPhA is committed to highlighting the vital role pharmacists play in antimicrobial stewardship and is participating in an AMS Canada Steering Committee; a national multi-stakeholder, multi-sector group led by the National Collaborating Centre for Infectious Diseases (NCCID) and HealthCareCAN. The mandate of this Committee is to further develop, scale and spread antimicrobial stewardship best practices across all sectors to battle the global public health problem of antimicrobial resistance.

Organizations for Health Action (HEAL)

HEAL is a coalition of national health associations and organizations dedicated to protecting and strengthening Canada’s health system. HEAL meets 4 times per year with the objectives of sharing information across organizations, working on those strategic issues that are of importance to all members, and meeting with external organizations to discuss policy issues of mutual interest and importance.